Unique transcriptional and chromatin profiles of memory CD8+ T cells
by DiSpirito, Joanna R., Ph.D., UNIVERSITY OF PENNSYLVANIA, 2009, 136 pages; 3395690

Abstract:

Compared to their naïve pre-cursors (TN), memory T cells (TM) can provide superior protection from pathogenic infections, and can cause significant pathology during unwanted immune responses, such as those underlying autoimmune diseases and transplant rejection. Thus, understanding the unique attributes of TM cells should facilitate development of new vaccines and immunoregulatory therapies. One distinguishing property of CD8+TM cells is their ability to rapidly execute effector functions following stimulation; however, the mechanisms underlying this ability are not well-defined. Specifically, little is known about whether or how a unique, stimulation-induced gene expression program contributes to TM cells' accelerated responses. Using whole genome mRNA profiling, we found that following stimulation, in comparison to T N cells, TM more robustly up-regulated a large set of genes that included amino acid metabolic enzymes and transporters, RNA processing factors, and transcription factors involved in cellular activation, showing that more robust transcript induction by TM cells is not limited to those encoding effector molecules In addition to more robust induction of this functionally diverse gene set, TM cells also uniquely induced a gene set involved in regulating nuclear export. In contrast, TN cells uniquely down-regulated factors that can condense chromatin, and we identified the repression of several histone deacetylases as an early event following TN activation, suggesting that changes in chromatin structure mediated by histone acetylation are important to CD8+ T cell differentiation. Based on these results, we developed a novel assay to measure the total, per cell level of di-acetylated histone H3 (diAcH3) in CD8 + T cells using flow cytometry. Interestingly, resting CD8 + TM cells had a higher level of this modification than their TN counterparts, and CD8+ TM primed in the absence of CD4+ T cell help, which are defective in rapid recall ability, had a lower level than TM primed in a CD4+ T cell-sufficient environment. Given the positive correlation of a locus's diAcH3 level with its transcriptional accessibility, these data suggest that in resting TM cells, diAcH3 may help keep loci open and accessible to the transcriptional machinery, particularly those whose expression is important for executing a rapid recall response.

 
AdviserHao Shen
SchoolUNIVERSITY OF PENNSYLVANIA
SourceDAI/B 71-01, p. , Feb 2010
Source TypeDissertation
SubjectsMolecular biology; Immunology
Publication Number3395690
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3395690
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.